NBIX · Neurocrine Biosciences, Inc.
Is NBIX setting up for a breakout, what are traders on X and the news saying, are its insiders buying, and how is the business doing? Everything Raspberry Trades measures on Neurocrine Biosciences, Inc., in one place.
Today's breakout radarIs NBIX setting up for a breakout?
Breakout Radar API →NBIX reports earnings on Nov 2, 2026 — a breakout right before a report can reverse on the numbers.
Not today. NBIX is not on today's radar: no tight base just under a resistance that has been tested again and again.
See the stocks that are setting up today →What are traders on X saying about NBIX?
Stock Sentiment API →Bulls: Q2 revenue was $959M, up about 39% year over year, with net income also rising, even as the stock trades roughly 21% below its late July high. On 10/14 a buyer paid about $575k for 500 Oct '27 $190 calls, all at the ask, on a brand-new contract that registered as new open interest. The setup was flagged as a trigger on 10/26 at $145.87.
Reading from Oct 28, 2026; each post classified by AI, weighted by engagement.
What is the news saying about NBIX?
News Sentiment API →No recent news reading for NBIX. The News Sentiment API reads today's headlines on any US stock.
Are NBIX insiders buying or selling?
Insider Trading API →Open-market trades only, from SEC Form 4 filings — option exercises, tax withholding and grants are left out.
- Sold · Boyer David W.$130K · Sep 14, 2026
- Sold · ABERNETHY MATT$363K · Sep 14, 2026
- Sold · BENEVICH ERIC$333K · Sep 9, 2026
- Sold · Norwalk Leslie V$228K · Jul 28, 2026
- Sold · Delaet Ingrid$791K · Jul 10, 2026
How is Neurocrine Biosciences, Inc.'s business doing?
Financial Statements API →| Quarter ended | Revenue | vs year before | Net income | EPS |
|---|---|---|---|---|
| Jun 30, 2026 | $959.0M | +39% | $144.4M | $1.39 |
| Mar 31, 2026 | $814.5M | +42% | $197.9M | $1.91 |
| Sep 30, 2025 | $794.9M | +28% | $209.5M | $2.04 |
| Jun 30, 2025 | $687.5M | +16% | $107.5M | $1.06 |
From the company's SEC filings (10-Q and 10-K).
Free account, no card: today's top 5 with charts, by email before the open.
Measured data, not recommendations. Not investment advice.